---
title: "Stelara (ustekinumab) in plaque psoriasis: Storage and supply questions"
description: "Storage and supply questions on Stelara (ustekinumab) in plaque psoriasis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: How supplied. Questions: What strengths does Stelara come in for subcutaneous injection? What are the NDC numbers for Stelara prefilled syringes and vials? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/storage-and-supply"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Stelara (ustekinumab) in plaque psoriasis: Storage and supply questions

Manufacturer: Janssen Biotech, Inc.  
Prescribing information: [Stelara](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf)

Storage and supply questions that apply to every indication of Stelara are on [Stelara (ustekinumab), all indications: Storage and supply](https://www.evicenter.com/medical-information/stelara/storage-and-supply).

## How supplied

<a id="stelara-strengths"></a>

### What strengths does Stelara come in for subcutaneous injection?

> “Subcutaneous Injection
> •	 Injection: 45 mg/0.5 mL or 90 mg/mL solution in a single-dose prefilled syringe
> •	 Injection: 45 mg/0.5 mL solution in a single-dose vial”

Source: [STELARA: Prescribing information, page 4, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=4)

Note: The 130 mg/26 mL intravenous vial is used only for Crohn's disease and ulcerative colitis induction and is not quoted.

<a id="stelara-ndc"></a>

### What are the NDC numbers for Stelara prefilled syringes and vials?

> “For Subcutaneous Use
> Prefilled Syringes
> •	 45 mg/0.5 mL (NDC 57894-060-03)
> •	 90 mg/mL (NDC 57894-061-03)
> Each prefilled syringe is equipped with a 27-gauge fixed ½ inch needle, a needle 
> safety guard, and a needle cover that contains dry natural rubber.
> Single-dose Vial
> •	 45 mg/0.5 mL (NDC 57894-060-02)”

Source: [STELARA: Prescribing information, page 12, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=12)

Note: The NDC of the 130 mg/26 mL intravenous vial, used only for Crohn's disease and ulcerative colitis, is not quoted.

## Related pages
- [Medical information: Stelara (ustekinumab): Plaque psoriasis](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis)
- [Indication](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/dosing-and-administration)
